Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Pityrosporum folliculitis presents as fine superficial follicular pustules and papules on the
trunk and upper extremities. Ketoconazole 2% foam was recently approved for the treatment of
seborrheic dermatitis in immunocompetent patients 12 years and older. Ketoconazole 2% foam is
felt to work by reducing the number of pityrosporum yeast organisms. Safety and efficacy of
ketoconazole 2% foam treatment for this fungal infections has not been established. This
study is to demonstrate efficacy and safety in the treatment of pityrosporum folliculitis.